IsoPlexis Announces Expansion into Asia Pacific
IsoPlexis expands sales of its single-cell proteomic analysis platform, IsoLight and IsoCode Chip, to the pharmaceutical and life sciences markets in China BRANFORD, Conn., Aug. 20, 2018 /PRNewswire/ — IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, announced today an exclusive agreement with Tekon Biotech, a leading instrumentation distributor, to... Read more